Mark Murcko

Mark Murcko is the founder of Relay Therapeutics, Inc., founded in 2015, serving as Independent Director.
Current jobs include Director at Morphic Therapeutic, Inc., Director at Quentis Therapeutics, Inc. since 2018, Director & Chief Innovation Officer at Dewpoint Therapeutics, Inc. since 2021, Director at Quvium UK Ltd. since 2014, Director at Human Immunology Biosciences, Inc., Director at RADD Therapeutics, Inc. since 2020, Director at Octant, Inc. since 2020, Director at Biohybrid Solutions Holding, Inc. since 2022, and Trustee at Gordon Research Conferences since 2016.
Former jobs include Director at SQZ Biotechnologies Co., Director at HIBio, Inc. from 2021 to 2023, Senior Vice President-Strategy at Schrödinger, Inc., and Chief Technology Officer & Vice President at Vertex Pharmaceuticals, Inc. from 1990 to 2011.
Education includes a doctorate from Yale University and an undergraduate degree from Fairfield University.